Use of incretin-based drugs and risk of cholangiocarcinoma: Scandinavian cohort study.
Ueda P, Wintzell V, Melbye M, Eliasson B, Svensson AM, Franzén S, Gudbjörnsdottir S, Hveem K, Jonasson C, Svanström H, Pasternak B.
Ueda P, et al. Among authors: jonasson c.
Diabetologia. 2021 Oct;64(10):2204-2214. doi: 10.1007/s00125-021-05508-1. Epub 2021 Jul 13.
Diabetologia. 2021.
PMID: 34254177
Free PMC article.